aminocaproic acid has been researched along with Aging in 6 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Excerpt | Relevance | Reference |
---|---|---|
" The therapeutic plasma concentration of EACA has been scientifically determined for the adult population, but the current recommended dosage for neonates has been empirically derived from adult studies." | 1.36 | The effective concentration of epsilon-aminocaproic Acid for inhibition of fibrinolysis in neonatal plasma in vitro. ( Eaton, MP; Liu, X; Tu, X; Wissler, RN; Yurka, HG; Zanghi, CN, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leroux, P | 1 |
Omouendze, PL | 1 |
Roy, V | 1 |
Dourmap, N | 1 |
Gonzalez, BJ | 1 |
Brasse-Lagnel, C | 1 |
Carmeliet, P | 1 |
Leroux-Nicollet, I | 1 |
Marret, S | 1 |
Yurka, HG | 1 |
Wissler, RN | 1 |
Zanghi, CN | 1 |
Liu, X | 1 |
Tu, X | 1 |
Eaton, MP | 1 |
Pashley, DH | 1 |
Tay, FR | 1 |
Yiu, C | 1 |
Hashimoto, M | 1 |
Breschi, L | 1 |
Carvalho, RM | 1 |
Ito, S | 1 |
Foster, JA | 1 |
Rich, CB | 1 |
DeSa, MD | 1 |
Jackson, AS | 1 |
Fletcher, S | 1 |
Ries, M | 1 |
Zenker, M | 1 |
Gaffney, PJ | 1 |
MacIomhair, M | 1 |
Lavelle, SM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Influence of the Number of Layers of a One Bottle Adhesive on the Longevity of Composite Resin Restorations in Primary Molars - Randomized Controlled Clinical Study.[NCT01680289] | 60 participants (Anticipated) | Interventional | 2012-08-31 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for aminocaproic acid and Aging
Article | Year |
---|---|
Collagen degradation by host-derived enzymes during aging.
Topics: Acid Etching, Dental; Aging; Aminocaproic Acid; Anti-Infective Agents, Local; Benzamidines; Chlorhex | 2004 |
5 other studies available for aminocaproic acid and Aging
Article | Year |
---|---|
Age-dependent neonatal intracerebral hemorrhage in plasminogen activator inhibitor 1 knockout mice.
Topics: Age Factors; Aging; Aminocaproic Acid; Animals; Animals, Newborn; Aprotinin; Cerebral Hemorrhage; Di | 2014 |
The effective concentration of epsilon-aminocaproic Acid for inhibition of fibrinolysis in neonatal plasma in vitro.
Topics: Adult; Aging; Aminocaproic Acid; Antifibrinolytic Agents; Cesarean Section; Dose-Response Relationsh | 2010 |
Improved methodologies for the isolation and purification of tropoelastin.
Topics: Aging; Amino Acids; Aminoacetonitrile; Aminocaproates; Aminocaproic Acid; Animals; Chickens; Chromat | 1980 |
Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
Topics: Adult; Aging; Aminocaproic Acid; Dose-Response Relationship, Drug; Fetal Blood; Fibrin; Fibrinolysis | 2000 |
Thrombus weight as a measure of hypercoagulability induced by drugs.
Topics: Adenosine Diphosphate; Aging; Aminocaproates; Aminocaproic Acid; Animals; Benzopyrans; Blood Coagula | 1979 |